CD9 (TSPAN29) (Motility-Related Protein-1)(CD9/1631), CF568 conjugate, 0.1mg/mL, Clone: [CD9/1631], Mouse, Monoclonal

Catalog Number: BOT-BNC681631-100
Article Name: CD9 (TSPAN29) (Motility-Related Protein-1)(CD9/1631), CF568 conjugate, 0.1mg/mL, Clone: [CD9/1631], Mouse, Monoclonal
Biozol Catalog Number: BOT-BNC681631-100
Supplier Catalog Number: BNC681631-100
Alternative Catalog Number: BOT-BNC681631-100-100UL
Manufacturer: Biotium
Host: Mouse
Category: Antikörper
Application: FC
Species Reactivity: Human
Immunogen: Recombinant full-length human CD9 protein
Conjugation: CF568
Alternative Names: Tetraspanin-29 (TSPAN29), BA-2/p24 antigen, BA2, BTCC1, CD9, Cell growth-inhibiting gene 2 protein (GIG2), DRAP27, Leukocyte antigen MIC3, Motility-related protein (MRP1), p24
CD9 is a type IV transmembrane glycoprotein with four transmembrane domains. CD9 on pre-B cells may play a role in cell-cell adhesion. In addition, CD9 may play a role in signal transduction mediated by interaction with low molecular weight GTP binding proteins. CD9 is expressed on early B cells, eosinophils, basophils and activated T cells and is a major component of the platelet cell surface. It is also expressed on most non-T acute lymphoblastic leukemia cells and on some acute myeloid and chronic lymphoid leukemia. Primary antibodies are available purified, or with a selection of fluorescent CF Dyes and other labels. CF Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF405S and CF405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
Clonality: Monoclonal
Concentration: 0.1 mg/mL
Clone Designation: [CD9/1631]
Molecular Weight: 24 kDa
UniProt: P21926
Buffer: PBS, 0.1% BSA, 0.05% azide
Source: Animal
Application Notes: ELISA: For coating, order Ab without BSA, Optimal dilution for a specific application should be determined.|Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody